Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 14 studies | 34% ± 15% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 28% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 209.65 | 2640 / 2642 | 87% | 2.10 | 614 / 705 |
esophagus | 96% | 52.56 | 1381 / 1445 | 49% | 0.88 | 89 / 183 |
stomach | 93% | 39.64 | 333 / 359 | 49% | 0.84 | 140 / 286 |
breast | 93% | 40.07 | 429 / 459 | 45% | 0.80 | 499 / 1118 |
ovary | 96% | 34.83 | 173 / 180 | 33% | 0.53 | 143 / 430 |
intestine | 100% | 74.14 | 964 / 966 | 29% | 0.44 | 151 / 527 |
adrenal gland | 90% | 25.70 | 233 / 258 | 34% | 0.50 | 78 / 230 |
kidney | 87% | 28.06 | 77 / 89 | 36% | 0.56 | 326 / 901 |
lung | 98% | 42.45 | 569 / 578 | 24% | 0.41 | 273 / 1155 |
bladder | 100% | 57.43 | 21 / 21 | 17% | 0.27 | 84 / 504 |
uterus | 99% | 65.49 | 168 / 170 | 16% | 0.32 | 74 / 459 |
thymus | 99% | 43.26 | 646 / 653 | 15% | 0.21 | 88 / 605 |
prostate | 98% | 53.35 | 240 / 245 | 14% | 0.19 | 70 / 502 |
skin | 90% | 32.72 | 1628 / 1809 | 20% | 0.30 | 94 / 472 |
blood vessel | 100% | 63.54 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 95% | 45.90 | 821 / 861 | 0% | 0 | 0 / 0 |
adipose | 93% | 33.96 | 1125 / 1204 | 0% | 0 | 0 / 0 |
spleen | 88% | 27.92 | 212 / 241 | 0% | 0 | 0 / 0 |
muscle | 84% | 22.01 | 671 / 803 | 0% | 0 | 0 / 0 |
pancreas | 52% | 11.23 | 171 / 328 | 19% | 0.26 | 33 / 178 |
peripheral blood | 39% | 9.35 | 359 / 929 | 0% | 0 | 0 / 0 |
liver | 34% | 6.91 | 76 / 226 | 4% | 0.06 | 17 / 406 |
lymph node | 0% | 0 | 0 / 0 | 34% | 0.47 | 10 / 29 |
tonsil | 0% | 0 | 0 / 0 | 20% | 0.33 | 9 / 45 |
eye | 0% | 0 | 0 / 0 | 6% | 0.08 | 5 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0005730 | Cellular component | nucleolus |
GO_0005737 | Cellular component | cytoplasm |
GO_0005694 | Cellular component | chromosome |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | TP53TG5 |
Protein name | TP53-target gene 5 protein (TP53-inducible gene 5 protein) |
Synonyms | C20orf10 |
Description | FUNCTION: May play a significant role in p53/TP53-mediating signaling pathway. . |
Accessions | Q9Y2B4 ENST00000372726.5 |